The long-term efficacy and safety of two different corticosteroids in chronic sarcoidosis

Respiratory Medicine

Volumn 91, Issue 8, 1997, Pages 449-460

  Rizzato, G ^a,c   Riboldi, A ^a   Imbimbo, B ^a   Torresin, A ^a   Milani, S ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CORTICOSTEROID; DEFLAZACORT; DIPEPTIDYL CARBOXYPEPTIDASE; GALLIUM 67; PREDNISONE;

ADULT; AMENORRHEA; ARTERIAL OXYGEN TENSION; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE PAIN; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CATARACT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; EDEMA; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FRACTURE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERTENSION; LUNG DIFFUSION; LUNG SARCOIDOSIS; LUNG SCINTISCANNING; MAJOR CLINICAL STUDY; MALE; MENORRHAGIA; PNEUMONIA; PRIORITY JOURNAL; SIDE EFFECT; SPIROMETRY; THORAX RADIOGRAPHY; TIME; WEIGHT GAIN;

EID: 0030851897     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90109-8     Document Type: Article

References (32)

1. Gennari C, Fusi L, Zacchei F et al. Effects of deflazacort on bone. In: Avioli L, Gennari C, Imbimbo B (eds) Glucocorticoid Effects and their Biological Consequences: Advances in Glucocorticoid Therapy. Amsterdam: Excerpta Medica, 1986, pp. 153-160.
2. Devogelaer J, Huaux J, Dufour J et al. Bone sparing action of deflazacort vs equivalent doses of prednisone: a double blind study in males with rheumatoid arthritis. In: Christiansen C, Johansen J, Riis B (eds). Osteoporosis 1987. Viborg: Norhaven A/S, 1987, pp. 1014-1015.
3. Loftus J, Allen R, Hesp R et al. Randomized, double-blind trial of deflazacort versus prednisone in juvenile chronic (or rheumatoid) arthritis: a relatively bone-sparing effect of deflazacort. Pediatrics 1991; 88: 428-436.
4. Olgaard K, Storm T, Wowern N et al. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double blind study on the high dose, long term effects of prednisone versus deflazacort. Calcif Tissue Int 1992; 50: 490-497.
5. Bonucci E, Lo Cascio V. Bone histomorphometry and biochemical data during glucocorticoid treatment. In: Avioli L, Gennari C, Imbimbo B (eds) Glucocorticoid Effects and their Biological Consequences: Advances in Glucocorticoid Therapy. Amsterdam: Excerpta Medica, 1986, pp. 135-144.
6. Gray R, Doherty S, Galloway J, Coulton L, Broe M, Kanis J. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. Arthritis Rheumatism 1991; 34: 287-295.
7. Rizzato G, Fraioli P, Montemurro L. Long-term therapy with deflazacort in chronic sarcoidosis. Chest 1991; 99: 301-309.
8. Rizzato G, Imbimbo B. Monitoring pulmonary sarcoidosis under prednisone and deflazacort treatment. In: Avioli L, Gennari C, Imbimbo B (eds) Glucocorticoid Effects and their Biological consequences: Advances in Glucocorticoid Therapy. Amsterdam: Excerpta Medica, 1986, pp. 71-77.
9. Rizzato G. Sarcoidosis. In: Rakel R (ed) Conn's Current Therapy. Philadelphia: WB Saunders, 1987, pp. 157-159.
10. 67Gallium lung scans. A study with follow up. Respiration 1983; 44: 360-367.
11. Ryan J, Chung A, Ammons C, Carlton M. A simple radioassay for ACE. Biochem J 1977; 167: 501-503.
12. Rizzato G, Brambilla I, Bertoli I, Conti F, Merlini R, Mantero O. Impaired airway function and pulmonary haemodynamics in sarcoidosis. In: Jones Williams W, Davies BH (eds) Sarcoidosis and Other Granulomatous Diseases. Cardiff: Alpha Omega Publishing Limited, 1980; pp. 349-360.
13. Rizzato G, Tosi G, Mella C, Montemurro L, Zanni D, Sisti S. Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women. Sarcoidosis 1988;1 5: 93-98.
14. Kleerekoper M. Vertebral fracture or vertebral deformity? Calcif tissue Int 1992; 50: 5-6.
15. Ettinger B, Black D, Nevitt M et al. and the Study of Osteoporotic Fractures Research Group. Contribution of vertebral deformities to chronic back pain and disability. J Bone Min Res 1992; 7: 449-456.
16. Kleerekoper M, Parfitt A, Ellis B. Measurement of vertebral fracture rates in osteoporosis. In: Christiansen C, Arnaud CD, Nordin B, Parfitt A, Peck W, Riggs B (eds) Copenhagen International Symposium on Osteoporosis. Copenhagen, 1984, pp. 103-109.
17. Ross P, Davis J, Epstein R, Wasnich R. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991; 114: 919-923.
18. Daniel W. Applied Nonparametric Statistics. Boston: Houghton Mifflin, 1978, pp. 110-114.
19. Mehta C, Patel N. A network algorithm for performing Fisher's exact test in r x c contingency tables. JASA 1983; 78: 427-434.
20. Maxwell S, Delaney H. Designing Experiments and Analyzing Data. Belmont, CA: Wadsworth, 1990, pp. 635-676.
21. Goodnight J, Harvey V. Least squares means in the fixed effects general model. SAS Technical Report R-103. Cary, NC: SAS Institute Inc., 1978.
22. Draper NR, Smith H. Applied Regression Analysis. New York: J Wiley and Sons, 1981, Chapters 3 and 5.
23. SAS Institute Inc. SAS/STAT User's Guide, Release 6.03 Edition. Cary, NC: SAS Institute Inc, 1988.
24. Genant H, Ettinger B, Harris S, Block J, Steiger P. Quantitative computed tomography in assessment of osteoporosis. In: Riggs L, Melton III J (eds) Osteoporosis. New York: Raven Press, 1988, pp. 221-249.
25. Saag K, Koehnke R, Caldwell J et al. Low dose long term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med 1994; 96: 115-123.
26. Haynes R. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman Gilman A, Rail T, Nies A, Taylor P (eds) The Pharmacological Basis of Therapeutics, 8th edition. New York: Pergamon Press, 1990, pp. 1431-1462.
27. Johns C. Sarcoidosis. In: Fishman A (ed) Pulmonary Diseases and Disorders, 2nd edition. New York: McGraw Hill, 1988, pp. 222-232.
28. Lukert B, Raisz L. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112: 352-364.
29. Lo Cascio V, Bonucci E, Imbimbo B et al. Bone loss in response to long-term glucocorticoid therapy. Bone and Mineral 1990; 8: 39-51.
30. Adachi JD, Bensen WG, Bell MJ et al Corticosteroid induced osteoporosis: follow up over 3 years. In: Christiansen C, Overgaard K (eds) Osteoporosis 1990. Third International Symposium on osteoporosis, Copenhagen, 1990, pp. 1747-1747.
31. Adinoff A, Hollister J. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983; 309: 265-268.
32. Melton L, Atkinson E, O'Fallon W, Wahner H, Riggs B. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 1993; 8: 1277-1283.